| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/26/2004 | WO2004046328A3 Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
| 08/26/2004 | WO2004045608A9 Pharmaceutical compositions containing a biguanide-glitazone combination |
| 08/26/2004 | WO2004043434B1 Oral testosterone delivery system with improved sustained release |
| 08/26/2004 | WO2004043351A3 Soluble oral patch with collagen and interlaced active ingredients |
| 08/26/2004 | WO2004041153A3 Pharmaceutical composition including low dosages of desmopressin |
| 08/26/2004 | WO2004037318A3 Method and system for intravesicular delivery of therapeutic agents |
| 08/26/2004 | WO2004037314A3 Patch and kit containing delayed-type hypersensitivity inducer |
| 08/26/2004 | WO2004037228A8 Sustained release compositions containing alfuzosin |
| 08/26/2004 | WO2004035523B1 Cationic cardiolipin analogs and use thereof |
| 08/26/2004 | WO2004034981A3 Compositions and methods for inhibiting group b streptococcus-induced pulmonary hypertension in neonates |
| 08/26/2004 | WO2004032826A3 Process for preparing tannate tablet capsule or other solid dosage forms |
| 08/26/2004 | WO2004026261A3 Composition containing ribavirin and use thereof |
| 08/26/2004 | WO2004021990A3 Compositions and kits for the removal of irritating compounds from bodily surfaces |
| 08/26/2004 | WO2004013310A3 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 08/26/2004 | WO2004009019A3 Method for incorporating cationic molecules into a substrate for increasing dispersibility of cationic molecules |
| 08/26/2004 | WO2004006863A3 Therapeutic devices for patterned cell growth |
| 08/26/2004 | WO2004004686A3 Cartilage enhancing food supplements and methods of preparing the same |
| 08/26/2004 | WO2004000234A3 Breath freshening and oral cleansing product with cinnamaldehyde |
| 08/26/2004 | WO2003103585A3 Methods of treating angiogenesis, tumor growth, and metastasis |
| 08/26/2004 | WO2003079976A3 A substance with sedative effect |
| 08/26/2004 | WO2003045354A8 Micropherules containing a pleuromutilin derivative |
| 08/26/2004 | US20040167804 Medical data communication notification and messaging system and method |
| 08/26/2004 | US20040167465 System and method for medical device authentication |
| 08/26/2004 | US20040167461 Dermal patch |
| 08/26/2004 | US20040167228 aerosols containing atenolol, pindolol, esmolol, propranolol, or metoprolol that are used in inhalation therapy |
| 08/26/2004 | US20040167225 Processes for the preparation of oral dosage formulations of modafinil |
| 08/26/2004 | US20040167223 Topical antibacterial formulations |
| 08/26/2004 | US20040167219 Carnitine-magnesium hydroxycitrate |
| 08/26/2004 | US20040167218 Ophthalmic fluid |
| 08/26/2004 | US20040167210 Crystalline base of citalopram |
| 08/26/2004 | US20040167205 Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions |
| 08/26/2004 | US20040167203 Absorption enhancing agents |
| 08/26/2004 | US20040167196 Treatment of benign prostatic hyperplasia |
| 08/26/2004 | US20040167162 therapy for infection of adenovirus, rhinovirus ; using an (amino or hydroxy)quinoline compound |
| 08/26/2004 | US20040167145 moderator of cholinergic agent; mixture of acetylcholinesterase inhibitors and opioiod receptor blockers |
| 08/26/2004 | US20040167140 [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides |
| 08/26/2004 | US20040167138 Antiischemic agents; brain disorders |
| 08/26/2004 | US20040167117 Calcium channel blockers administered into nose |
| 08/26/2004 | US20040167100 Illudin analogs useful as antitumor agents |
| 08/26/2004 | US20040167099 Mucoadhesive tetracycline formulations |
| 08/26/2004 | US20040167089 Immunostimulatory nucleic acid molecules |
| 08/26/2004 | US20040167085 Useful for the treatment of hypercholesterolemia |
| 08/26/2004 | US20040167079 using 2-deoxyglucose to treat cancer and to improve patient outcome when administered at a therapeutically effective dose, optionally co-administered with other anti-cancer drugs, or in combination with surgical resection or radiation therapy |
| 08/26/2004 | US20040167063 fatty acid triglyceride and a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, e.g., transesterification product of a vegetable oil with glycerol, propylene glycol or sorbitol |
| 08/26/2004 | US20040167039 containing polyol(s) and a gelling agent; increases in temperature by at least 5 degrees C. upon exposure to moisture and which has a Maximum Energy Release Index of at least 11 mJ/mg.; use for vaginal lubrication, administration of active ingredients and for preventing or treating dysmenorrhea |
| 08/26/2004 | US20040167034 Emulsion and dispersion formulations and method |
| 08/26/2004 | US20040166231 Hard sugar coating method |
| 08/26/2004 | US20040166174 Diagnosing bacteria infections; administering aqueou solution of silver colloids |
| 08/26/2004 | US20040166171 Antiulcer agents; anaerobic infections |
| 08/26/2004 | US20040166168 Methods for micronization of hydrophobic drugs |
| 08/26/2004 | US20040166164 Storage stability; uniformity bioavailability ; sustained release; solid phase crystallization; solvent saturation; recovering |
| 08/26/2004 | US20040166162 Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid |
| 08/26/2004 | US20040166161 Pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance and respective processes of producing same and a cup-shaped envelope of same |
| 08/26/2004 | US20040166160 Modulate release of cyclobenzaprine; multilayer tablet containing hydrated form of cyclobenzaprine; controlling concentration in blood |
| 08/26/2004 | US20040166159 Brain diosrders; controlling dopamine concentration |
| 08/26/2004 | US20040166158 Bonding; used as drug; sustained release; supplying to mucous membrane |
| 08/26/2004 | US20040166157 Sustained release; oral administering of drug ; veterinary medicine |
| 08/26/2004 | US20040166156 Direct compression polymer tablet core |
| 08/26/2004 | US20040166155 Drug activation process and vibrational mill therefor |
| 08/26/2004 | US20040166153 Pharmaceutical formulation |
| 08/26/2004 | US20040166151 Administering prodrug; anticancer agents; antiinflammatory agents; infections |
| 08/26/2004 | US20040166150 Mixture of expression vector for antihemophilic factor and lipid |
| 08/26/2004 | US20040166149 Optimizing giant unilamellar vesicle (GUV) growth in a physiological buffer and artificial cell based biosensor |
| 08/26/2004 | US20040166148 Sustained release of drug |
| 08/26/2004 | US20040166147 Multilayer; backing layer containing reservoir, covering with aperture , adhesive and lining |
| 08/26/2004 | US20040166146 Phototherapy bandage |
| 08/26/2004 | US20040166145 Multilayer; containing apertured film containing pouches which releases cosmetics |
| 08/26/2004 | US20040166141 Methods and devices for modulating the immune response |
| 08/26/2004 | US20040166140 Overcoating with biodegradable polymer; reservoir containing drugs; sustained release |
| 08/26/2004 | US20040166124 Jetting lipid and bioactive material containing liposomes |
| 08/26/2004 | US20040166123 Allergen dosage form |
| 08/26/2004 | US20040166122 Adenovirus formulations |
| 08/26/2004 | US20040166083 Personal care water-in-oil emulsion products |
| 08/26/2004 | US20040166080 Thermoplastic coating and binding agent for medicinal forms |
| 08/26/2004 | US20040166067 Pharmaceutical compositions |
| 08/26/2004 | US20040166066 Compositions to reduce congestion and methods for application thereof to the nasal membrane |
| 08/26/2004 | US20040166065 anticholinergics in the treatment of respiratory complaints, particularly in the treatment of inflammatory and/or obstructive diseases of the respiratory tract, particularly for treating asthma or COPD (chronic obstructive pulmonary disease). |
| 08/26/2004 | US20040166060 Liposomal encapsulation of alpha particle emittors and uses thereof |
| 08/26/2004 | DE20320413U1 Kosmetikum mit empfindlichen Inhaltsstoffen Cosmetic with sensitive ingredients |
| 08/26/2004 | DE19920555B4 Verwendung von nanoskaligen Metallseifen The use of nanoscale metal soaps |
| 08/26/2004 | DE10306789A1 Composition for administration to living organisms, useful for labeling treated organisms, comprises active agent and a protein complex comprising viral capsomers |
| 08/26/2004 | DE10306761B3 Verfahren zur Herstellung von sterilen pharmazeutischen Wirkstoffen A process for the preparation of sterile pharmaceutical agents |
| 08/26/2004 | DE10305811A1 Surgical implant, preferably in net form, comprises basic structure containing anabolic steroid and corticosteroid to accelerate healing and reduce scar contraction |
| 08/26/2004 | DE10305661A1 Composition used for controlled, colon-specific release of alpha-lipoic acid or derivative, for treatment of inflammatory colon diseases, containing cationogenic polymer, organic acid and polymeric auxiliary |
| 08/26/2004 | DE10305319A1 Treating bacterial infections of respiratory organs comprises local administration of ciprofloxacin, enrofloxacin or their sparingly soluble salts in solid form |
| 08/26/2004 | DE10305137A1 Transdermale therapeutische Abgabesysteme mit einem Butenolid Transdermal therapeutic delivery systems with a butenolide |
| 08/26/2004 | DE10300187A1 Kaugummizusammensetzung mit pflanzlichen Wirkstoffen The chewing gum composition with herbal ingredients |
| 08/26/2004 | DE102004003224A1 Transdermal patch for administering a drug at a temperature above skin temperature comprises a drug-impermeable backing layer, a drug-containing silicone-based matrix layer, a release liner and a heating element |
| 08/26/2004 | CA2517491E Injectable liquid formulation of paracetamol |
| 08/26/2004 | CA2515919A1 Method of producing structures using centrifugal forces |
| 08/26/2004 | CA2515641A1 Methods and dosage forms with modified layer geometry |
| 08/26/2004 | CA2515534A1 New pharmaceutical compositions based on anticholinergics and tace-inhibitors |
| 08/26/2004 | CA2515400A1 Method for treating hypothyroidism |
| 08/26/2004 | CA2515397A1 New pharmaceutical compositions based on anticholinergics and anti-tnf antibodies |
| 08/26/2004 | CA2515395A1 New pharmaceutical compositions based on anticholinergics and soluble tnf receptor fusion proteins |
| 08/26/2004 | CA2515394A1 Enantiomeric amphetamine compositions for the treatment of adhd |
| 08/26/2004 | CA2515391A1 Use of p-glycoprotein inhibitor surfactants at the surface of a colloidal carrier |
| 08/26/2004 | CA2515292A1 Random and non-random alkylene oxide polymer alloy compositions |
| 08/26/2004 | CA2515192A1 Compositions for neuronal tissue regeneration |
| 08/26/2004 | CA2515083A1 Topical delivery of cosmetic agents |